Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01499862 · ClinicalTrials.gov registry record · Phase 4
Mobility Training Using a Bionic Knee Orthosis in Patients Chronic Post-Stroke: A Case Series
A Phase 4 study of Stroke, sponsored by Tibion Bionics.
- Completed
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT01499862: Completed Phase 4 study of Stroke, sponsored by Tibion Bionics.
NCT01499862 is a Phase 4 study of Stroke that has completed, run by Tibion Bionics. The registered enrollment target is 3 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01499862, a Phase 4 study of Stroke, has completed, sponsored by Tibion Bionics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study examined the effect of task-oriented mobility training in three persons chronic post-stroke using a novel, wearable, mobile intention-based robotic orthosis (Tibion Bionic Leg).
Primary Outcome
Ambulation speed, in meters per second, as obtained by the Ten (10) Meter Walk Test (10 MWT). The 10 MWT measures the time required to walk 10 meters at the subject's comfortable walking pace.
Conditions Studied
Interventions
- DEVICE Tibion Bionic Leg
Study Locations (1)
California
- Bakar Community Center at the University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-12 |
| Phase | Phase 4 |
What the finished NCT01499862 record still lists
NCT01499862 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Tibion Bionic Leg is the first listed.
NCT01499862 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01499862 about?
NCT01499862 is a clinical study titled "Mobility Training Using a Bionic Knee Orthosis in Patients Chronic Post-Stroke: A Case Series". This pilot study examined the effect of task-oriented mobility training in three persons chronic post-stroke using a novel, wearable, mobile intention-based robotic orthosis (Tibion Bionic Leg).
What is the current status of trial NCT01499862?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2009-06. Estimated completion is 2011-12.
What conditions does trial NCT01499862 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT01499862?
The interventions under investigation include: Tibion Bionic Leg (DEVICE).
Who is sponsoring clinical trial NCT01499862?
This trial is sponsored by Tibion Bionics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01499862 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01499862's enrollment target sits among peer trials
3 448th of 454 higher than 2 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
International Care Bundle Evaluation in Cerebral Hemorrhage Research
RECRUITING · Phase 4
-
Xeomin® and Gait Related Mobility After Stroke
RECRUITING · Phase 4
-
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
RECRUITING · Phase 4
-
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
ACTIVE NOT RECRUITING · Phase 4
-
SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke
COMPLETED · Phase 4
-
Gait Training For Acute Stroke: Functional Neuromuscular Stimulation (FNS) and Weight Supported Treadmill Training
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia